A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer.
Saved in:
| Title: | A Phase Ib Study of Indirect Immunization with Oregovomab and Toll-like-Receptor-3 Stimulation with Hiltonol® in Patients with Recurrent Platinum-Resistant Ovarian Cancer. |
|---|---|
| Authors: | Holloway RW; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA., Temkin SM; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA., Gordon SW; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA., Gupta S; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea., Jada SR; CanariaBio, Inc., Seoul 06044, Gyeonggi-do, Republic of Korea., Ahmad S; Gynecologic Oncology Program, AdventHealth Cancer Institute, Orlando, FL 32804, USA., McGuire WP; Division of Gynecologic Oncology, Virginia Commonwealth University, Richmond, VA 23298, USA. |
| Source: | Current oncology (Toronto, Ont.) [Curr Oncol] 2025 Sep 24; Vol. 32 (10). Date of Electronic Publication: 2025 Sep 24. |
| Publication Type: | Journal Article; Clinical Trial, Phase I |
| Journal Info: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 9502503 Publication Model: Electronic Cited Medium: Internet ISSN: 1718-7729 (Electronic) Linking ISSN: 11980052 NLM ISO Abbreviation: Curr Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
